From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology

A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …

[HTML][HTML] Endocannabinoid-mediated control of synaptic transmission

M Kano, T Ohno-Shosaku… - Physiological …, 2009 - journals.physiology.org
The discovery of cannabinoid receptors and subsequent identification of their endogenous
ligands (endocannabinoids) in early 1990s have greatly accelerated research on …

The endocannabinoid system as an emerging target of pharmacotherapy

P Pacher, S Bátkai, G Kunos - Pharmacological reviews, 2006 - ASPET
The recent identification of cannabinoid receptors and their endogenous lipid ligands has
triggered an exponential growth of studies exploring the endocannabinoid system and its …

The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?

RC Pierce, V Kumaresan - Neuroscience & biobehavioral reviews, 2006 - Elsevier
In this review we will critically assess the hypothesis that the reinforcing effect of virtually all
drugs of abuse is primarily dependent on activation of the mesolimbic dopamine system …

[HTML][HTML] The endocannabinoid system and cannabidiol's promise for the treatment of substance use disorder

Y Chye, E Christensen, N Solowij, M Yücel - Frontiers in psychiatry, 2019 - frontiersin.org
Substance use disorder is characterized by repeated use of a substance, leading to
clinically significant distress, making it a serious public health concern. The …

Neurobiology of addiction: An integrative review

A Goodman - Biochemical pharmacology, 2008 - Elsevier
Evidence that psychoactive substance use disorders, bulimia nervosa, pathological
gambling, and sexual addiction share an underlying biopsychological process is …

Involvement of the endocannabinoid system in drug addiction

R Maldonado, O Valverde, F Berrendero - Trends in neurosciences, 2006 - cell.com
Recent studies have shown that the endocannabinoid system is involved in the common
neurobiological mechanism underlying drug addiction. This system participates in the …

The neurocircuitry of addiction: an overview

MW Feltenstein, RE See - British journal of pharmacology, 2008 - Wiley Online Library
Drug addiction presents as a chronic relapsing disorder characterized by persistent drug‐
seeking and drug‐taking behaviours. Given the significant detrimental effects of this disease …

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

T Sugiura, S Kishimoto, S Oka, M Gokoh - Progress in lipid research, 2006 - Elsevier
2-Arachidonoylglycerol (2-AG) is a unique molecular species of monoacylglycerol isolated
in 1995 from rat brain and canine gut as an endogenous ligand for the cannabinoid …

[HTML][HTML] There and back again: a tale of norepinephrine and drug addiction

D Weinshenker, JP Schroeder - Neuropsychopharmacology, 2007 - nature.com
Fueled by anatomical, electrophysiological, and pharmacological analyses of endogenous
brain reward systems, norepinephrine (NE) was identified as a key mediator of both natural …